TheraRadar

Pharma Intelligence, Simplified

← All Targets

ACE

20 drugs
Cardiovascular
Market Leader
HYDROCHLOROTHIAZIDE
JUBILANT CADISTA
8
approved indications
20
Approved Drugs
12
Companies
15
Indications
1
Therapeutic Areas
Unlock Full Target Intelligence PRO
Competitive landscape by company (12 companies)
All 20 approved drugs
Therapeutic area breakdown
Full indication list (15 indications)
Patent cliff analysis
Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo

Drugs by Company

Aurobindo Pharma 5 drugs
AZURITY 2 drugs
BAUSCH 2 drugs

By Therapeutic Area

Cardiovascular 19 drugs
Other 1 drugs